| Figure 1‑1: ENT Endoscopic and Bronchoscopic Device Market Share Ranking by Segment, U.S., 2022 (1 of 2) |
| Figure 1‑2: ENT Endoscopic and Bronchoscopic Device Market Share Ranking by Segment, U.S., 2022 (2 of 2) |
| Figure 1‑3: Companies Researched in This Report |
| Figure 1‑4: Factors Impacting the ENT Endoscopic and Bronchoscopic Device Market by Segment, U.S. (1 of 2) |
| Figure 1‑5: Factors Impacting the ENT Endoscopic and Bronchoscopic Device Market by Segment, U.S. (2 of 2) |
| Figure 1‑6: Recent Events in the ENT Endoscopic and Bronchoscopic Device Market, U.S., 2019 – 2022 |
| Figure 1‑7: ENT Endoscopic and Bronchoscopic Device Procedures Covered |
| Figure 1‑8: Procedure Codes Investigated |
| Figure 1‑9: Endoscopic and Bronchoscopic Device Markets Covered (1 of 4) |
| Figure 1‑10: Endoscopic and Bronchoscopic Device Markets Covered (2 of 4) |
| Figure 1‑11: Endoscopic and Bronchoscopic Device Markets Covered (3 of 4) |
| Figure 1‑12: Endoscopic and Bronchoscopic Device Markets Covered (4 of 4) |
| Figure 1‑13: Key Report Updates |
| Figure 1‑14: Version History |
| Figure 2‑1: ENT Endoscopic and Bronchoscopic Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) |
| Figure 2‑2: ENT Endoscopic and Bronchoscopic Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) |
| Figure 2‑3: ENT Endoscopic and Bronchoscopic Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) |
| Figure 4‑1: Single-Use Endoscope Devices by Company |
| Figure 4‑2: Rigid Laryngoscope Devices by Company (1 of 2) |
| Figure 4‑3: Rigid Laryngoscope Devices by Company (2 of 2) |
| Figure 4‑4: Flexible Laryngoscope Devices by Company |
| Figure 4‑5: Direct Laryngoscope Devices by Company |
| Figure 4‑6: Reusable Rhinoscopes/Sinuscopes by company |
| Figure 4‑7: Reusable Otoscopes by Company |
| Figure 4‑8: Powered Instruments, Capital Equipment Devices by Company |
| Figure 4‑9: Powered Instruments, Disposables Devices by Company |
| Figure 4‑10: Hand Instrument Devices by Company |
| Figure 4‑11: Surgical Energy Devices by Company |
| Figure 4‑12: Balloon Sinus Dilation Devices by Company |
| Figure 4‑13: Drug Eluting Stent Devices by Company |
| Figure 4‑14: Rigid Bronchoscope Devices by Company |
| Figure 4‑15: Flexible Bronchoscope Devices by Company |
| Figure 4‑16: Ultrasound Bronchoscope Devices by Company |
| Figure 4‑17: Single Use Bronchoscope Devices by Company |
| Figure 4‑18: Bronchoscopic Hand Instrument Devices by Company |
| Figure 4‑19: Metal Stent Devices by Company |
| Figure 4‑20: Silicone Stent Devices by Company |
| Figure 4‑21: Bronchial Biopsy Forceps Devices by Company |
| Figure 4‑22: Transbronchial Needle Aspiration Devices by Company |
| Figure 4‑23: Foreign Body Removal Devices by Company |
| Figure 4‑24: Class 2 Device Recall Ambu VivaSight 2 DLT |
| Figure 4‑25: Class 1 Device Recall King Vision Video Adapter Size 1/2 |
| Figure 4‑26: Class 2 Device Recall Nasopharyngolaryngoscope |
| Figure 4‑27: Class 2 Device Recall KARL STORZ |
| Figure 4‑28: Class 2 Device Recall KARL STORZ |
| Figure 4‑29: Class 2 Device Recall Video Laryngoscope |
| Figure 4‑30: Class 2 Device Recall McGrath |
| Figure 4‑31: Class 2 Device Recall Olympus ENDOEYE HD II Video Telescopes |
| Figure 4‑32: Class 2 Device Recall Pentax Rigid Laryngostroboscopes |
| Figure 4‑33: Class 2 Device Recall Rusch Greenlite Single Use Metal Laryngoscope Blade for Fiber Optic System |
| Figure 4‑34: Class 2 Device Recall Rusch |
| Figure 4‑35: Class 2 Device Recall RUSCH POLARIS Laryngoscope |
| Figure 4‑36: Class 1 Device Recall GlideScope Core OneTouch Smart Cable |
| Figure 4‑37: Class 2 Device Recall GlideScope Video Laryngoscope |
| Figure 4‑38: Class 2 Device Recall Medtronic |
| Figure 4‑39: Class 2 Device Recall Entellus Medical Shaver System |
| Figure 4‑40: Class 2 Device Recall Stryker Instruments S2 Mini Foot Pedal |
| Figure 4‑41: Class 2 Device Recall Stryker Sustainability Solutions (SSS) |
| Figure 4‑42: Class 2 Device Recall Olympus |
| Figure 4‑43: Class 2 Device Recall Bronchoscope Tubes |
| Figure 4‑44: Class 2 Device Recall Reprocessed Coronary Sinus Diagnostic EP Catheter |
| Figure 4‑45: Class 2 Device Recall Stryker PROFESS |
| Figure 4‑46: Class 2 Device Recall Ethicon |
| Figure 4‑47: Class 2 Device Recall Ethicon |
| Figure 4‑48: Class 2 Device Recall Covidien Emprint Ablation Catheter with Thermosphere Technology Bronchoscopic Ablation |
| Figure 4‑49: Class 2 Device Recall Covidien Sonicision Battery Charger |
| Figure 4‑50: Class 2 Device Recall Covidien |
| Figure 4‑51: Class 2 Device Recall Flexible Bronchoscope |
| Figure 4‑52: Class 2 Device Recall Intubation Fiberscope |
| Figure 4‑53: Class 2 Device Recall LYMOL Medical Elite X Class Rigid Bronchoscope System |
| Figure 4‑54: Class 2 Device Recall EVIS EXERA III |
| Figure 4‑55: Class 2 Device Recall Olympus |
| Figure 4‑56: Class 2 Device Recall Bronchofiberscopes |
| Figure 4‑57: Class 2 Device Recall EVIS EXERA Bronchovideoscopes |
| Figure 4‑58: Class 2 Device Recall Olympus BFQ180 Bronchoscope |
| Figure 4‑59: Class 2 Device Recall Olympus MAJ209 Single Use Suction Valve (MAJ209) |
| Figure 4‑60: Class 1 Device Recall Atrium |
| Figure 4‑61: WARNING LETTER Lymol Medical Corporation |
| Figure 4‑62: Class 2 Device Recall Captura Serrated Forceps with Spike |
| Figure 4‑63: Class 2 Device Recall ASPIRATION NEEDLE VIZISHOT |
| Figure 4‑64: Class 2 Device Recall ASPIRATION NEEDLE |
| Figure 4‑65: Class 2 Device Recall Hobbs |
| Figure 4‑66: Class 2 Device Recall Hobbs Bronchial Cytology Brushes |
| Figure 4‑67: Class 2 Device Recall Hobbs |
| Figure 4‑68: Class 2 Device Recall Olympus |
| Figure 4‑69: Study of Cost-effectiveness of the Airway Management in Thoracic Surgery |
| Figure 4‑70: Direct Versus Video Laryngoscope Trial (device) |
| Figure 4‑71: C-MAC Video Stylet vs. Video Endoscope |
| Figure 4‑72: Procedural Efficiency and Organisational Impact of Rhino Laryngoscopes Procedures in Consults |
| Figure 4‑73: GlideScope Videolaryngoscopy in Patients with Reduced Mouth Opening |
| Figure 4‑74: VivaSight-SL Versus Videolaryngoscopy in Expected Difficult Airway (VivaOP) |
| Figure 4‑75: Comparison of Videolaryngoscopy and Direct Laryngoscopy in Pediatric Airway Management |
| Figure 4‑76: Conventional Intubation Versus VivaSight™-SL (VivaITN) |
| Figure 4‑77: Comparison of Endotracheal Intubation Using Flexible Fiberoptic Bronchoscopy Versus Flexible Intubation Video Endoscope (FIVE) in Obese Patients Undergoing Elective Surgeries Under General Anesthesia: A Randomized Controlled Trial |
| Figure 4‑78: A Study of the ENSEAL® X1 Curved Jaw Tissue Sealer and Generator G11 in Thoracic, Urologic, and Ear, Nose, and Throat (ENT) Procedures |
| Figure 4‑79: A Prospective, Multi-Center Evaluation of the ENSEAL X1 Large Jaw Tissue Sealer |
| Figure 4‑80: Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis. |
| Figure 4‑81: A Clinical Evaluation of PROPEL® Contour Sinus Implant (EXPAND) |
| Figure 4‑82: Treatment of Chronic Frontal Sinusitis by a Simple Technique Using Dilation Balloons (SIBA) |
| Figure 4‑83: Video-Laryngoscope Alone or With Bronchoscope for Predicted Difficult Intubation (COMBO) |
| Figure 4‑84: Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill Patients (VEBUS) |
| Figure 4‑85: Evaluation of a Disposable Flexible Bronchoscope, aScope IV (EVAL) |
| Figure 4‑86: TRAcheostomy with Single Use Bronchoscopes vs. Conventional Bronchoscopes |
| Figure 4‑87: Reusable Flexible Bronchoscopes Versus Single Use Bronchoscopes: a Satisfaction Survey |
| Figure 4‑88: Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView |
| Figure 4‑89: Airway Stents for Excessive Dynamic Airway Collapse |
| Figure 4‑90: Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent |
| Figure 4‑91: Biodegradable Airway Stent Post Lung Transplant |
| Figure 4‑92: Central Malignant Airway Obstructions: Medical Treatment Alone Versus Endoscopic and Medical Treatment (EVERMORE) |
| Figure 4‑93: Stent Versus Balloon Dilatation in Patients with Tracheal Benign Stenosis (STROBE) |
| Figure 4‑94: Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant |
| Figure 4‑95: Evaluation of the Synergistic Impact of Needle and Forceps Biopsy with Electromagnetic Navigation Bronchoscopy |
| Figure 4‑96: Needle-Based Confocal Laser Endomicroscopy with Fluorescein and Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Lung Cancer in Patients With Peripheral Pulmonary Nodules |
| Figure 4‑97: Thin and Ultrathin Bronchoscopy with Transbronchial Needle Aspiration and Radial Probe Endobronchial Ultrasound for Peripheral Pulmonary Lesions |
| Figure 4‑98: EBUS TBNA After PET/CT in Diagnosing Patients with Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation Therapy |
| Figure 4‑99: Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma |
| Figure 4‑100: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle |
| Figure 4‑101: Foreign Body Ingestion During COVID-19 Lockdown |
| Figure 4‑102: Comparison of Patients with and Without Foreign Body Aspiration After Bronchoscopy. |
| Figure 4‑103: High Flow Nasal Cannula in Comparison to Apneic Oxygenation During Foreign Body Removal by Rigid Bronchoscope |
| Figure 5‑1: ENT Endoscopic Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 5‑2: Leading Competitors, ENT Endoscopic Device Market, U.S., 2022 |
| Figure 5‑3: SWOT Analysis, Acclarent |
| Figure 5‑4: SWOT Analysis, Ambu |
| Figure 5‑5: SWOT Analysis, Karl Storz |
| Figure 5‑6: SWOT Analysis, Medtronic |
| Figure 5‑7: SWOT Analysis, Olympus |
| Figure 5‑8: SWOT Analysis, Pentax |
| Figure 5‑9: SWOT Analysis, Smith & Nephew |
| Figure 5‑10: SWOT Analysis, Stryker |
| Figure 6‑1: Procedure Codes Investigated, U.S., 2021 |
| Figure 6‑2: Total ENT Procedures by Anatomy, U.S., 2019 – 2029 |
| Figure 6‑3: Otological Procedures by Type, U.S., 2019 – 2029 |
| Figure 6‑4: Tympanoplasty / Mastoidectomy Procedures, U.S., 2019 – 2029 |
| Figure 6‑5: Myringotomy Procedures, U.S., 2019 – 2029 |
| Figure 6‑6: Nose Procedures by Type, U.S., 2019 – 2029 |
| Figure 6‑7: Sinus Procedures, U.S., 2019 – 2029 |
| Figure 6‑8: Turbinate Reduction Procedures, U.S., 2019 – 2029 |
| Figure 6‑9: Septoplasty Procedures, U.S., 2019 – 2029 |
| Figure 6‑10: Throat Procedures by Type, U.S., 2019 – 2029 |
| Figure 6‑11: Tonsillectomy Procedures, U.S., 2019 – 2029 |
| Figure 6‑12: Adenoidectomy Procedures, U.S., 2019 – 2029 |
| Figure 6‑13: Combined Procedures, U.S., 2019 – 2029 |
| Figure 7‑1: ENT Endoscope Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 7‑2: Single-Use ENT Endoscope Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 7‑3: Total Single-Use ENT Endoscope Market, U.S., 2019 – 2029 |
| Figure 7‑4: Single-Use Rhinolaryngoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 7‑5: Total Single-Use Rhinolaryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑6: Hospital Single-Use Rhinolaryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑7: Non-Hospital Single-Use Rhinolaryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑8: Single-Use Intubation Endoscope Market by Device Type, U.S., 2019 – 2029 (US$M) |
| Figure 7‑9: Total Single-Use Intubation Endoscope Market, U.S., 2019 – 2029 |
| Figure 7‑10: Flexible Single-Use Intubation Endoscope Market, U.S., 2019 – 2029 |
| Figure 7‑11: Single-Use Fiberoptic Blade Market, U.S., 2019 – 2029 |
| Figure 7‑12: Single-Use Video Blade Market, U.S., 2019 – 2029 |
| Figure 7‑13: Single-Use Intubation Endoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 7‑14: Hospital Single-Use Intubation Endoscope Market, U.S., 2019 – 2029 |
| Figure 7‑15: Non-Hospital Single-Use Intubation Endoscope Market, U.S., 2019 – 2029 |
| Figure 7‑16: Reusable Laryngoscope Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 7‑17: Total Reusable Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑18: Rigid Laryngoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 7‑19: Total Rigid Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑20: Hospital Rigid Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑21: Non-Hospital Rigid Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑22: Flexible Laryngoscope Market by Device Type, U.S., 2019 – 2029 (US$M) |
| Figure 7‑23: Total Flexible Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑24: Video Flexible Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑25: Fiber Optic Flexible Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑26: Flexible Laryngoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 7‑27: Hospital Flexible Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑28: Non-Hospital Flexible Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑29: Direct Laryngoscope Market by Device Type, U.S., 2019 – 2029 (US$M) |
| Figure 7‑30: Total Direct Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑31: Direct Laryngoscope Blade Market by Device Type, U.S., 2019 – 2029 (US$M) |
| Figure 7‑32: Total Direct Blade Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑33: Direct Video Blade Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑34: Direct Non-Video Blade Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑35: Direct Laryngoscope Blade Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 7‑36: Total Direct Blade Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑37: Hospital Direct Blade Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑38: Non-Hospital Direct Blade Laryngoscope Market, U.S., 2019 – 2029 |
| Figure 7‑39: Direct Laryngoscope Handle Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 7‑40: Hospital Direct Laryngoscope Handle Market, U.S., 2019 – 2029 |
| Figure 7‑41: Non-Hospital Direct Laryngoscope Handle Market, U.S., 2019 – 2029 |
| Figure 7‑42: Reusable Rhinoscope/Sinuscope Market, U.S., 2019 – 2029 |
| Figure 7‑43: Reusable Otoscope Market, U.S., 2019 – 2029 |
| Figure 7‑44: Leading Competitors, ENT Endoscope Market, U.S., 2022 |
| Figure 8‑1: ENT Powered Instrument Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 8‑2: ENT Powered Instrument Capital Equipment Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 8‑3: Total ENT Powered Instrument Capital Equipment Market, U.S., 2019 – 2029 |
| Figure 8‑4: ENT Power Shaver Market, U.S., 2019 – 2029 |
| Figure 8‑5: ENT Power Drill Market, U.S., 2019 – 2029 |
| Figure 8‑6: ENT Powered Instrument Disposables Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 8‑7: Total ENT Powered Instrument Disposables Market, U.S., 2019 – 2029 |
| Figure 8‑8: ENT Shaver Blade Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 8‑9: Total ENT Shaver Blade Market, U.S., 2019 – 2029 |
| Figure 8‑10: Navigation ENT Shaver Blade Market, U.S., 2019 – 2029 |
| Figure 8‑11: Regular ENT Shaver Blade Market, U.S., 2019 – 2029 |
| Figure 8‑12: ENT Drill Bur Market, U.S., 2019 – 2029 |
| Figure 8‑13: Leading Competitors, ENT Powered Instrument Market, U.S., 2022 |
| Figure 9‑1: ENT Hand Instrument Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 9‑2: ENT Hand Instrument Market, U.S., 2019 – 2029 |
| Figure 9‑3: Sinus Hand Instrument Market, U.S., 2019 – 2029 |
| Figure 9‑4: Laryngeal Hand Instrument Market, U.S., 2019 – 2029 |
| Figure 9‑5: Otology Hand Instrument Market, U.S., 2019 – 2029 (US$M) |
| Figure 9‑6: Leading Competitors, ENT Hand Instrument Market, U.S., 2022 |
| Figure 10‑1: ENT Surgical Energy Device Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 10‑2: Capital Equipment Market, U.S., 2019 – 2029 |
| Figure 10‑3: RF & Ultrasonic Probe Market, U.S., 2019 – 2029 |
| Figure 10‑4: Leading Competitors, ENT Surgical Energy Device Market, U.S., 2022 |
| Figure 11‑1: Balloon Dilation Device Market, U.S., 2019 – 2029 |
| Figure 11‑2: Leading Competitors, Balloon Dilation Device Market, U.S., 2022 |
| Figure 12‑1: Drug-Eluting Stent Market, U.S., 2019 – 2029 |
| Figure 12‑2: Leading Competitors, Drug-Eluting Stent Market, U.S., 2022 |
| Figure 13‑1: Bronchoscopic Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 13‑2: Leading Competitors, Bronchoscopic Device Market, U.S., 2022 |
| Figure 13‑3: SWOT Analysis, Ambu |
| Figure 13‑4: SWOT Analysis, Boston Scientific |
| Figure 13‑5: SWOT Analysis, Getinge |
| Figure 13‑6: SWOT Analysis, Karl Storz |
| Figure 13‑7: SWOT Analysis, Olympus |
| Figure 13‑8: SWOT Analysis, Pentax |
| Figure 14‑1: Bronchoscopic Procedures by Type, U.S., 2019 – 2029 |
| Figure 14‑2: Tracheobronchial Stenting and Dilation Procedures by Type, U.S., 2019 – 2029 |
| Figure 14‑3: Pulmonary Sampling Procedures by Type, U.S., 2019 – 2029 |
| Figure 14‑4: Pulmonary Biopsy Procedures by Type, U.S., 2019 – 2029 |
| Figure 14‑5: Tumor Removal Procedures, U.S., 2019 – 2029 |
| Figure 14‑6: Foreign Body Removal Procedures, U.S., 2019 – 2029 |
| Figure 15‑1: Bronchoscope Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 15‑2: Rigid Bronchoscope Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 15‑3: Rigid Bronchoscope Device Market, U.S., 2019 – 2029 |
| Figure 15‑4: Rigid Bronchoscopic Tube Market, U.S., 2019 – 2029 |
| Figure 15‑5: Rigid Bronchoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 15‑6: Hospital Rigid Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑7: Non-Hospital Rigid Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑8: Flexible Bronchoscope Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 15‑9: Total Flexible Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑10: Fiber Flexible Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑11: Video Flexible Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑12: Flexible Bronchoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 15‑13: Hospital Flexible Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑14: Non-Hospital Flexible Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑15: Ultrasound Bronchoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 15‑16: Hospital Ultrasound Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑17: Non-Hospital Ultrasound Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑18: Ultrasound Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑19: Single-Use Bronchoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 15‑20: Hospital Single-Use Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑21: Non-Hospital Single-Use Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑22: Single-Use Bronchoscope Market, U.S., 2019 – 2029 |
| Figure 15‑23: Leading Competitors, Bronchoscope Market, U.S., 2022 |
| Figure 16‑1: Bronchoscopic Hand Instrument Market, U.S., 2019 – 2029 |
| Figure 16‑2: Leading Competitors, Bronchoscopic Hand Instrument Market, U.S., 2022 |
| Figure 17‑1: Tracheobronchial Stent Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 17‑2: Tracheobronchial Stent Market, U.S., 2019 – 2029 |
| Figure 17‑3: Metal Tracheobronchial Stent Market, U.S., 2019 – 2029 |
| Figure 17‑4: Silicone Tracheobronchial Stent Market, U.S., 2019 – 2029 |
| Figure 17‑5: Leading Competitors, Tracheobronchial Stent Market, U.S., 2022 |
| Figure 18‑1: Bronchoscopic Biopsy Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 18‑2: Bronchial Forceps Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 18‑3: Total Bronchial Forceps Market, U.S., 2019 – 2029 |
| Figure 18‑4: Disposable Bronchial Forceps Market, U.S., 2019 – 2029 |
| Figure 18‑5: Reusable Bronchial Forceps Market, U.S., 2019 – 2029 |
| Figure 18‑6: Transbronchial Aspiration Needle Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 18‑7: Total Transbronchial Aspiration Needle Market, U.S., 2019 – 2029 |
| Figure 18‑8: Conventional TBNA Market, U.S., 2019 – 2029 |
| Figure 18‑9: EBUS-TBNA Market, U.S., 2019 – 2029 |
| Figure 18‑10: Leading Competitors, Bronchoscopic Biopsy Device Market, U.S., 2022 |
| Figure 19‑1: Foreign Body Removal Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 19‑2: Foreign Body Removal Device Market, U.S., 2019 – 2029 |
| Figure 19‑3: Disposable Foreign Body Removal Device Market, U.S., 2019 – 2029 |
| Figure 19‑4: Reusable Foreign Body Removal Device Market, U.S., 2019 – 2029 |
| Figure 19‑5: Leading Competitors, Foreign Body Removal Device Market, U.S., 2022 |
Single-use devices, especially single-use endoscopes and bronchoscopes, have become increasingly popular in the ENT endoscopic and bronchoscopic device market. The benefits of single-use devices include a decreased risk of infection and no reprocessing after use. Recently, single-use devices have gained significant traction in the bronchoscope market.
In 2022, the leading competitor in the overall ENT endoscopic and bronchoscopic device market was Acclarent. The company participated solely in the balloon dilation device segment of the ENT endoscopic device market, where it held a majority share.
